Caren Michelle Coffy-mccormick, APRN | |
292 Carter Dr, Suite B, Middletown, DE 19709-5846 | |
(302) 449-0710 | |
(302) 449-1770 |
Full Name | Caren Michelle Coffy-mccormick |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 17 Years |
Location | 292 Carter Dr, Middletown, Delaware |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043461627 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | LE-0000176 (Delaware) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mccormick And Associates Of Middletown, Llc | 5294905162 | 2 |
News Archive
Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.
Massage therapy student volunteers from Cortiva Institute - Pennsylvania School of Massage Therapy will lend their time and skills to the Bayada Regatta, one of the first adaptive rowing competitions for athletes with disabilities, on Saturday, August 28 from 9:00 AM to 4:00 PM at St. Joseph's University Boathouse, 2200 Kelly Drive in Philadelphia.
ADCs are used for a new type of targeted therapy that consists of a specific anti-cancer antibody or antibody fragment linked to a potent anti-cancer therapeutic.
Researchers at Aston Business School in Birmingham (UK) have been part of a national government review to improve the health and wellbeing of staff in the NHS.
› Verified 1 days ago
Entity Name | Mccormick & Associates Of Middletown, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316235385 PECOS PAC ID: 5294905162 Enrollment ID: O20110901000136 |
News Archive
Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.
Massage therapy student volunteers from Cortiva Institute - Pennsylvania School of Massage Therapy will lend their time and skills to the Bayada Regatta, one of the first adaptive rowing competitions for athletes with disabilities, on Saturday, August 28 from 9:00 AM to 4:00 PM at St. Joseph's University Boathouse, 2200 Kelly Drive in Philadelphia.
ADCs are used for a new type of targeted therapy that consists of a specific anti-cancer antibody or antibody fragment linked to a potent anti-cancer therapeutic.
Researchers at Aston Business School in Birmingham (UK) have been part of a national government review to improve the health and wellbeing of staff in the NHS.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Caren Michelle Coffy-mccormick, APRN 292 Carter Dr, Suite B, Middletown, DE 19709-5846 Ph: (302) 449-0710 | Caren Michelle Coffy-mccormick, APRN 292 Carter Dr, Suite B, Middletown, DE 19709-5846 Ph: (302) 449-0710 |
News Archive
Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.
Massage therapy student volunteers from Cortiva Institute - Pennsylvania School of Massage Therapy will lend their time and skills to the Bayada Regatta, one of the first adaptive rowing competitions for athletes with disabilities, on Saturday, August 28 from 9:00 AM to 4:00 PM at St. Joseph's University Boathouse, 2200 Kelly Drive in Philadelphia.
ADCs are used for a new type of targeted therapy that consists of a specific anti-cancer antibody or antibody fragment linked to a potent anti-cancer therapeutic.
Researchers at Aston Business School in Birmingham (UK) have been part of a national government review to improve the health and wellbeing of staff in the NHS.
› Verified 1 days ago
Ms. Annette Rickolt, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 350 Noxontown Rd, Middletown, DE 19709 Phone: 302-285-4200 | |
Karen L Panunto, EDD, MSN, RN, APN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 118 Sandhill Drive, Suite 201 Delaware Sleep Disorder Centers, Middletown, DE 19709 Phone: 877-335-7533 Fax: 877-575-3337 |